Related Experiment Videos
Biomarkers in psychotropic drug development.
Saeeduddin Ahmed1, P David Mozley, William Z Potter
1Lily Research Laboratories, Indianapolis, Indiana, USA. ahmed_saeed@lilly.com
Summary
Biomarkers are crucial for developing new psychotropic drugs, improving clinical trial accuracy, safety, and efficiency. They aid in assessing drug effects and reducing development time and costs.
Area of Science:
- Neuroscience
- Pharmacology
- Biomarker Research
Background:
- Clinical drug development is evolving towards mechanistically-driven approaches.
- Biomarkers are increasingly vital for assessing drug performance and safety.
Purpose of the Study:
- To review the role of biomarkers in developing novel psychotropic agents.
- To highlight the benefits of incorporating biomarkers in drug development.
Main Methods:
- Review of existing literature on biomarker application in psychotropic drug development.
- Emphasis on the utility of biomarkers for central nervous system exposure and effects.
Main Results:
- Biomarkers facilitate accurate dose estimation in clinical trials.
- Emerging biomarkers show promise for Alzheimer disease drug development.
- Biomarkers improve signal detection for drug efficacy and safety.
Conclusions:
- Biomarkers enhance the quality, safety, and efficiency of psychotropic drug development.
- The integration of biomarkers supports a shift towards more precise, mechanistically-driven drug discovery.